Detalhe da pesquisa
1.
S100ß as a serum marker in endocrine resistant breast cancer.
BMC Med
; 15(1): 79, 2017 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28399921
2.
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.
Breast Cancer Res
; 17: 123, 2015 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341737
3.
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.
Ther Adv Endocrinol Metab
; 13: 20420188221113140, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874313
4.
Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers.
Front Cell Dev Biol
; 9: 630503, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33816477
5.
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy.
Clin Cancer Res
; 27(14): 3980-3989, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016642
6.
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.
Clin Cancer Res
; 15(6): 2098-106, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19276281
7.
Cytochrome P450 1B1 expression in rat esophageal tumorigenesis promoted by gastric and duodenal reflux.
Mol Carcinog
; 48(2): 110-7, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18618592
8.
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy.
Mol Cancer Ther
; 18(10): 1731-1743, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289138
9.
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.
Endocr Relat Cancer
; 15(3): 745-53, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18469157
10.
The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.
Front Endocrinol (Lausanne)
; 9: 594, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30416486
11.
Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1).
Cardiovasc Res
; 69(1): 207-17, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16165110
12.
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
Clin Cancer Res
; 21(23): 5371-9, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26240272
13.
Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.
Cancer Res
; 74(9): 2533-44, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24648347
14.
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.
Sci Transl Med
; 6(229): 229ra41, 2014 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24670685
15.
Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.
Cancer Res
; 72(1): 220-9, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072566
16.
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
Clin Cancer Res
; 18(12): 3305-15, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22550166
17.
RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer.
FEBS Lett
; 585(15): 2537-44, 2011 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21763315
18.
The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
Endocr Relat Cancer
; 17(1): 255-64, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032008
19.
Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].
Cancer Res
; 70(4): 1585-94, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20145129